Contributo: Fierabracci Tirzepatide Once Weekly for the treatment of Obesity Ania M. Jastreboff, M.D., Ph.D., Louis J. Aronne, M.D., Nadia N. Ahmad, M.D., M.P.H., Sean Wharton, M.D., Pharm.D., Lisa Connery, M.D., Breno
Contributo: De Luca Ryan Howard, MD1; Grace F. Chao, MD, MS; Jie Yang, PhD; Jyothi R. Thumma,; David E. Arterburn,; Dana A. Telem; Justin B. Dimick JAMA Surg. 2022;157(3):248-256. doi:10.1001/jamasurg.2021.6898
Contributo: Paola Fierabracci Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A randomized, Double –Blind Crossover Trial. Yvo JM, Op den Komp, Marilies de Ligt,
Contributo: Paola Fierabracci Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both CombinedJR Lundgren, C Janus, SBK Jensen et al.N Engl J
Contributo: Paola Fierabracci Commento a: Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Obes Surg.Epub 2019 Apr 25, Julià H,
Contributo di FIERABRACCI Commento a: Change in Lean Mass, absolute and relative muscle strength and physical performance after gastric by pass surgery Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T,
